PrimeRFP SCOUT · Federal Contract Recompete Brief

36C24226D0007NEW JERSEY CHEMO compounding — Optum Infusion Services 308, LLC

Optum Infusion Services 308, LLC holds $3.6M across 17 federal awards, concentrated at Department of Veterans Affairs (VA). This PIID sits alongside 5 related awards in the incumbent pipeline. Set-aside status: Unrestricted.

242-Network Contract Office 02 (36C242)
Awarding office
Optum Infusion Services 308, LLC
Recipient
—
Estimated value
6505
PSC
Unrestricted
Set-aside

Watch this recompete

One email. No account. We ping you if the window moves.

Contract facts

Unrestricted
Contract number36C24226D0007
Also listed as36C242-26-D-0007
Agency242-Network Contract Office 02 (36C242)
Awarding office242-Network Contract Office 02 (36C242)
Awarding agencyDepartment of Veterans Affairs (VA)
Funding agencyDepartment of Veterans Affairs (VA)
IncumbentOptum Infusion Services 308, LLC
UEIRN5UVE9XMJN4
PSC6505

NEW JERSEY CHEMO COMPOUNDING is a federal Unrestricted award for 242-Network Contract Office 02 (36C242) held by Optum Infusion Services 308, LLC. Estimated value —.

Bonuses end Sept 30

Want the durability read on 36C24226D0007? One Pursuit Analysis, $500, inside 48 business hours.

  • 48 business hours
  • $500
  • Credits toward the Pack
Buy one Pursuit Analysis — $500

Incumbent footprint

Public record

Optum Infusion Services 308, LLC — $3.6M obligated across 17 awards (firm-wide, all agencies).

Sole agency: Department of Veterans Affairs (VA)
Department of Veterans Affairs (VA)$3.6M · 100% of firm total
Open full company profile →

Related awards

Same incumbent
36C24226N0119
CHEMO COMPOUNDING
$1.6M
Sep 30, 2026
36C25626N0215
HAZARDOUS COMPOUNDING SERVICES
$300K
Sep 30, 2026
36C25726N0093
AMARILLO VA PHARMACY COMPOUNDING FOR ONCOLOGY MEDICATIONS
$225K
Oct 31, 2026
36C25626N0560
CONTINGENCY MEDICATION COMPOUNDING SERVICES - EO 14398
$500K
May 6, 2027
36C24526P0129
IV SUPPORT
$300K
Aug 26, 2026

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

More in SCOUT
Size up the competition →Research the incumbent →

Frequently asked questions

What is contract 36C24226D0007?

36C24226D0007 (NEW JERSEY CHEMO compounding) is a 242-Network Contract Office 02 (36C242) award with an estimated value of —, currently held by Optum Infusion Services 308, LLC. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is 36C242-26-D-0007?

36C242-26-D-0007 is the dashed form of PIID 36C24226D0007 (NEW JERSEY CHEMO compounding), held by Optum Infusion Services 308, LLC. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded 36C24226D0007?

242-Network Contract Office 02 (36C242) awarded 36C24226D0007 to Optum Infusion Services 308, LLC.

Who is the incumbent on 36C24226D0007?

Optum Infusion Services 308, LLC is the incumbent with $3.6M across 17 related awards in SCOUT’s public footprint.

When does Optum Infusion Services 308, LLC’s 36C24226D0007 come up for recompete?

SCOUT tracks a period-of-performance end of an unstated date. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Want the durability read on 36C24226D0007? One Pursuit Analysis, $500, inside 48 business hours.

One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.

Get the free Exposure Check

No card · under a minute · then the Sprint menu

Buy one Pursuit Analysis — $500

Credits toward the Sprint Pack

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthly
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/36C24226D0007